166 related articles for article (PubMed ID: 25391439)
21. Assessment of vascular invasion in gastric cancer: a comparative study.
Gresta LT; Rodrigues-Júnior IA; de Castro LP; Cassali GD; Cabral MM
World J Gastroenterol; 2013 Jun; 19(24):3761-9. PubMed ID: 23840114
[TBL] [Abstract][Full Text] [Related]
22. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
[TBL] [Abstract][Full Text] [Related]
23. Enhanced detection of lymphovascular invasion in small rectal neuroendocrine tumors using D2-40 and Elastica van Gieson immunohistochemical analysis.
Kitagawa Y; Ikebe D; Hara T; Kato K; Komatsu T; Kondo F; Azemoto R; Komoda F; Tanaka T; Saito H; Itami M; Yamaguchi T; Suzuki T
Cancer Med; 2016 Nov; 5(11):3121-3127. PubMed ID: 27748061
[TBL] [Abstract][Full Text] [Related]
24. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40.
Walgenbach-Bruenagel G; Tolba RH; Varnai AD; Bollmann M; Hirner A; Walgenbach KJ
Eur Surg Res; 2006; 38(5):438-44. PubMed ID: 16912482
[TBL] [Abstract][Full Text] [Related]
25. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
[TBL] [Abstract][Full Text] [Related]
27. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
Canter D; Guzzo T; Resnick M; Magerfleisch L; Sonnad S; Bergey M; Tomazewski J; Vaughn D; Van Arsdalen K; Malkowicz B
BJU Int; 2008 Sep; 102(8):952-7. PubMed ID: 18485042
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
29. Reevaluation of lymphovascular invasion in gastric cancer using endothelial markers D2-40 and EVG: Enhanced detection, better predictor of lymph node metastasis and biological aggressiveness.
Liu J; Li H; Zhou P; Cai T; Tang Z; Wang Y; Cui Y; Sun Y; Wang X
J Surg Oncol; 2021 May; 123(8):1736-1741. PubMed ID: 33772776
[TBL] [Abstract][Full Text] [Related]
30. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
[TBL] [Abstract][Full Text] [Related]
31. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
[TBL] [Abstract][Full Text] [Related]
32. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers.
He KW; Sun JJ; Liu ZB; Zhuo PY; Ma QH; Liu ZY; Yu ZY
Medicine (Baltimore); 2017 Nov; 96(44):e8490. PubMed ID: 29095309
[TBL] [Abstract][Full Text] [Related]
34. A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
Mari A; Kimura S; Foerster B; Abufaraj M; D'Andrea D; Gust KM; Shariat SF
Urol Oncol; 2018 Jun; 36(6):293-305. PubMed ID: 29685374
[TBL] [Abstract][Full Text] [Related]
35. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
Liu L; Lin H; Shen G; Liu Y; Qin X; Yuan Y; Wang B; Xue L
BMC Cancer; 2023 Apr; 23(1):370. PubMed ID: 37087442
[TBL] [Abstract][Full Text] [Related]
38. Concordance of lymphovascular invasion diagnosed in penile carcinoma with and without the immunohistochemical markers ERG and CD31.
Feng MA; Ebel JJ; Shabsigh A; Zynger DL
Histol Histopathol; 2016 Mar; 31(3):293-8. PubMed ID: 26452171
[TBL] [Abstract][Full Text] [Related]
39. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
40. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
